Any 0 3 0 3 O
current 4 11 4 11 O
or 12 14 12 14 O
pre 15 18 15 18 O
- 18 19 18 19 O
existing 19 27 19 27 O
hematologic 28 39 28 39 B-chronic_disease
malignancy 40 50 40 50 I-chronic_disease

Auto- 0 5 51 56 O
or 6 8 57 59 O
allo 9 13 60 64 O
- 13 14 64 65 O
immunity 14 22 65 73 O
: 22 23 73 74 O
Examples 24 32 75 83 O
must 33 37 84 88 O
include 38 45 89 96 O
objective 46 55 97 106 O
physical 56 64 107 115 O
findings 65 73 116 124 O
that 74 78 125 129 O
include 79 86 130 137 O
, 86 87 137 138 O
but 88 91 139 142 O
are 92 95 143 146 O
not 96 99 147 150 O
limited 100 107 151 158 O
to 108 110 159 161 O
any 111 114 162 165 O
one 115 118 166 169 O
of 119 121 170 172 O
alopecia 122 130 173 181 B-chronic_disease
, 130 131 181 182 O
severe 132 138 183 189 O
rashes 139 145 190 196 B-chronic_disease
, 145 146 196 197 O
uveitis 147 154 198 205 B-chronic_disease
, 154 155 205 206 O
joint 156 161 207 212 O
pain 162 166 213 217 O
with 167 171 218 222 O
redness 172 179 223 230 O
or 180 182 231 233 O
swelling 183 191 234 242 O
or 192 194 243 245 O
limitation 195 205 246 256 O
of 206 208 257 259 O
movement 209 217 260 268 O
that 218 222 269 273 O
is 223 225 274 276 O
not 226 229 277 280 O
a 230 231 281 282 O
result 232 238 283 289 O
of 239 241 290 292 O
infection 242 251 293 302 O
, 251 252 302 303 O
lupus 253 258 304 309 B-chronic_disease
- 258 259 309 310 O
like 259 263 310 314 O
lesions 264 271 315 322 O
, 271 272 322 323 O
and 273 276 324 327 O
granulomas 277 287 328 338 B-chronic_disease

CD4 0 3 339 342 B-clinical_variable
plus 4 8 343 347 O
CD45RA+ 9 16 348 355 B-clinical_variable
lymphocytes 17 28 356 367 B-clinical_variable
: 28 29 367 368 O
absolute 30 38 369 377 O
number 39 45 378 384 O
less 46 50 385 389 O
than 51 55 390 394 O
or 56 58 395 397 O
equal 59 64 398 403 O
to 65 67 404 406 O
50 68 70 407 409 B-upper_bound
percent 71 78 410 417 I-upper_bound
of 79 81 418 420 O
the 82 85 421 424 O
LLN 86 89 425 428 B-clinical_variable
OR 90 92 429 431 O
T 93 94 432 433 B-clinical_variable
- 94 95 433 434 I-clinical_variable
cell 95 99 434 438 I-clinical_variable
receptor 100 108 439 447 I-clinical_variable
excision 109 117 448 456 I-clinical_variable
circles 118 125 457 464 I-clinical_variable
( 126 127 465 466 I-clinical_variable
TRECs)squared 127 140 466 479 I-clinical_variable
less 141 145 480 484 O
than 146 150 485 489 O
or 151 153 490 492 O
equal 154 159 493 498 O
to 160 162 499 501 O
5 163 164 502 503 B-upper_bound
percent 165 172 504 511 I-upper_bound
of 173 175 512 514 O
normal 176 182 515 521 O
for 183 186 522 525 O
age 187 190 526 529 B-age

CD4 0 3 530 533 B-clinical_variable
+ 3 4 533 534 I-clinical_variable
lymphocytes 5 16 535 546 I-clinical_variable
: 16 17 546 547 O
absolute 18 26 548 556 O
number 27 33 557 563 O
less 34 38 564 568 O
than 39 43 569 573 O
or 44 46 574 576 O
equal 47 52 577 582 O
to 53 55 583 585 O
50 56 58 586 588 B-upper_bound
percent 59 66 589 596 I-upper_bound
of 67 69 597 599 I-upper_bound
the 70 73 600 603 I-upper_bound
lower 74 79 604 609 I-upper_bound
limit 80 85 610 615 I-upper_bound
of 86 88 616 618 I-upper_bound
normal 89 95 619 625 I-upper_bound
( 96 97 626 627 I-upper_bound
LLN 97 100 627 630 I-upper_bound
) 100 101 630 631 I-upper_bound

Childhood 0 9 632 641 B-cancer
malignancy 10 20 642 652 I-cancer
( 21 22 653 654 O
occurring 22 31 654 663 O
before 32 38 664 670 O
18 39 41 671 673 B-upper_bound
years 42 47 674 679 I-upper_bound
of 48 50 680 682 O
age 51 54 683 686 B-age
) 54 55 686 687 O
in 56 58 688 690 O
the 59 62 691 694 O
patient 63 70 695 702 O
or 71 73 703 705 O
a 74 75 706 707 O
first 76 81 708 713 O
degree 82 88 714 720 O
relative 89 97 721 729 O

Current 0 7 730 737 O
treatment 8 17 738 747 B-treatment
with 18 22 748 752 O
any 23 26 753 756 O
chemotherapeutic 27 43 757 773 B-treatment
agent 44 49 774 779 I-treatment

Documented 0 10 780 790 O
HIV-1 11 16 791 796 B-chronic_disease
infection 17 26 797 806 I-chronic_disease

Documented 0 10 807 817 O
active 11 17 818 824 O
Hepatitis 18 27 825 834 B-chronic_disease
B 28 29 835 836 I-chronic_disease
infection 30 39 837 846 O

Documented 0 10 847 857 O
to 11 13 858 860 O
be 14 16 861 863 O
negative 17 25 864 872 O
for 26 29 873 876 O
HIV 30 33 877 880 B-chronic_disease
infection 34 43 881 890 I-chronic_disease
by 44 46 891 893 O
genome 47 53 894 900 O
PCR 54 57 901 904 B-treatment

Expected 0 8 905 913 B-clinical_variable
survival 9 17 914 922 I-clinical_variable
of 18 20 923 925 O
at 21 23 926 928 O
least 24 29 929 934 O
120 30 33 935 938 B-lower_bound
days 34 38 939 943 I-lower_bound

Failure 0 7 944 951 O
to 8 10 952 954 O
grow 11 15 955 959 O
in 16 18 960 962 O
height 19 25 963 969 B-clinical_variable
: 25 26 969 970 O
less 27 31 971 975 O
than 32 36 976 980 O
or 37 39 981 983 O
equal 40 45 984 989 O
to 46 48 990 992 O
3 49 50 993 994 B-upper_bound
rd 51 53 995 997 I-upper_bound
percentile 54 64 998 1008 I-upper_bound
for 65 68 1009 1012 O
age 69 72 1013 1016 B-age

HLA 0 3 1017 1020 B-treatment
typing 4 10 1021 1027 O
of 11 13 1028 1030 O
the 14 17 1031 1034 O
patient 18 25 1035 1042 O
will 26 30 1043 1047 O
have 31 35 1048 1052 O
been 36 40 1053 1057 O
performed 41 50 1058 1067 O
before 51 57 1068 1074 O
enrollment 58 68 1075 1085 O

Hospitalization 0 15 1086 1101 B-treatment
of 16 18 1102 1104 O
any 19 22 1105 1108 O
duration 23 31 1109 1117 O
for 32 35 1118 1121 O
infection 36 45 1122 1131 B-chronic_disease

If 0 2 1132 1134 O
previously 3 13 1135 1145 B-treatment
transplanted 14 26 1146 1158 I-treatment
, 26 27 1158 1159 O
must 28 32 1160 1164 O
be 33 35 1165 1167 O
greater 36 43 1168 1175 O
than 44 48 1176 1180 O
or 49 51 1181 1183 O
equal 52 57 1184 1189 O
to 58 60 1190 1192 O
18 61 63 1193 1195 B-lower_bound
months 64 70 1196 1202 I-lower_bound
post 71 75 1203 1207 B-treatment
haploidentical 76 90 1208 1222 I-treatment
HSCT 91 95 1223 1227 I-treatment

If 0 2 1228 1230 O
serum 3 8 1231 1236 B-clinical_variable
IgM 9 12 1237 1240 I-clinical_variable
< 12 13 1240 1241 O
normal 13 19 1241 1247 O
for 20 23 1248 1251 O
age 24 27 1252 1255 B-age

Infections 0 10 1256 1266 B-chronic_disease
( 11 12 1267 1268 O
not 12 15 1268 1271 O
including 16 25 1272 1281 O
molluscum 26 35 1282 1291 B-chronic_disease
, 35 36 1291 1292 O
warts 37 42 1293 1298 B-chronic_disease
or 43 45 1299 1301 O
mucocutaneous 46 59 1302 1315 B-chronic_disease
candidiasis 60 71 1316 1327 I-chronic_disease
; 71 72 1327 1328 O
see 73 76 1329 1332 O
vii 77 80 1333 1336 O
and 81 84 1337 1340 O
viii 85 89 1341 1345 O
below 90 95 1346 1351 O
): 95 97 1351 1353 O
greater 98 105 1354 1361 O
than 106 110 1362 1366 O
or 111 113 1367 1369 O
equal 114 119 1370 1375 O
to 120 122 1376 1378 O
3 123 124 1379 1380 B-lower_bound
significant 125 136 1381 1392 O
new 137 140 1393 1396 O
or 141 143 1397 1399 O
chronic 144 151 1400 1407 O
active 152 158 1408 1414 B-chronic_disease
infections 159 169 1415 1425 I-chronic_disease
during 170 176 1426 1432 O
the 177 180 1433 1436 O
12 181 183 1437 1439 B-upper_bound
months 184 190 1440 1446 I-upper_bound
preceding 191 200 1447 1456 I-upper_bound
evaluation 201 211 1457 1467 O
for 212 215 1468 1471 O
enrollment 216 226 1472 1482 O

Isolation 0 9 1483 1492 O
of 10 12 1493 1495 O
a 13 14 1496 1497 O
bacteria 15 23 1498 1506 O
, 23 24 1506 1507 O
fungus 25 31 1508 1514 O
, 31 32 1514 1515 O
or 33 35 1516 1518 O
virus 36 41 1519 1524 O
from 42 46 1525 1529 O
biopsy 47 53 1530 1536 B-treatment
, 53 54 1536 1537 O
skin 55 59 1538 1542 B-chronic_disease
lesion 60 66 1543 1549 I-chronic_disease
, 66 67 1549 1550 O
blood 68 73 1551 1556 O
, 73 74 1556 1557 O
nasal 75 80 1558 1563 B-treatment
washing 81 88 1564 1571 I-treatment
, 88 89 1571 1572 O
bronchoscopy 90 102 1573 1585 B-treatment
, 102 103 1585 1586 O
cerebrospinal 104 117 1587 1600 O
fluid 118 123 1601 1606 O
or 124 126 1607 1609 O
stool 127 132 1610 1615 O
likely 133 139 1616 1622 O
to 140 142 1623 1625 O
be 143 145 1626 1628 O
an 146 148 1629 1631 O
etiologic 149 158 1632 1641 O
agent 159 164 1642 1647 O
of 165 167 1648 1650 O
infection 168 177 1651 1660 B-chronic_disease

Lymphocyte 0 10 1661 1671 B-treatment
proliferative 11 24 1672 1685 I-treatment
response 25 33 1686 1694 I-treatment
to 34 36 1695 1697 O
each 37 41 1698 1702 O
of 42 44 1703 1705 O
2 45 46 1706 1707 O
mitogens 47 55 1708 1716 B-clinical_variable
, 55 56 1716 1717 O
phytohemagglutinin 57 75 1718 1736 B-clinical_variable
( 76 77 1737 1738 I-clinical_variable
PHA 77 80 1738 1741 I-clinical_variable
) 80 81 1741 1742 I-clinical_variable
and 82 85 1743 1746 O
concanavalin 86 98 1747 1759 B-clinical_variable
A 99 100 1760 1761 I-clinical_variable
( 101 102 1762 1763 I-clinical_variable
ConA 102 106 1763 1767 I-clinical_variable
) 106 107 1767 1768 I-clinical_variable
, 107 108 1768 1769 O
is 109 111 1770 1772 O
squared 112 119 1773 1780 O
25 120 122 1781 1783 O
percent 123 130 1784 1791 O
with 131 135 1792 1796 O
a 136 137 1797 1798 O
normal 138 144 1799 1805 O
control 145 152 1806 1813 O

Medical 0 7 1814 1821 O
lab 8 11 1822 1825 O
data 12 16 1826 1830 O
( 17 18 1831 1832 O
historical 18 28 1832 1842 O
) 28 29 1842 1843 O
of 30 32 1844 1846 O
severe 33 39 1847 1853 O
B 40 41 1854 1855 B-chronic_disease
cell 42 46 1856 1860 I-chronic_disease
dysfunction 47 58 1861 1872 I-chronic_disease
( 59 60 1873 1874 O
low 60 63 1874 1877 O
or 64 66 1878 1880 O
absent 67 73 1881 1887 O
IgG 74 77 1888 1891 B-clinical_variable
levels 78 84 1892 1898 I-clinical_variable
, 84 85 1898 1899 O
failed 86 92 1900 1906 O
immune 93 99 1907 1913 O
response 100 108 1914 1922 O
to 109 111 1923 1925 O
vaccines 112 120 1926 1934 B-treatment
) 120 121 1934 1935 O

Memory 0 6 1936 1942 B-clinical_variable
B 7 8 1943 1944 I-clinical_variable
Cells 9 14 1945 1950 I-clinical_variable
: 14 15 1950 1951 O
absolute 16 24 1952 1960 O
numberless 25 35 1961 1971 O
than 36 40 1972 1976 O
or 41 43 1977 1979 O
equal 44 49 1980 1985 O
to 50 52 1986 1988 O
50percent 53 62 1989 1998 B-upper_bound
of 63 65 1999 2001 O
LLN 66 69 2002 2005 B-clinical_variable

Molecular 0 9 2006 2015 O
spectratype 10 21 2016 2027 O
analysis- 22 31 2028 2037 O
absent 32 38 2038 2044 O
or 39 41 2045 2047 O
very 42 46 2048 2052 O
oligoclonal 47 58 2053 2064 O
( 59 60 2065 2066 O
1 60 61 2066 2067 B-lower_bound
- 61 62 2067 2068 O
3 62 63 2068 2069 B-upper_bound
dominant 64 72 2070 2078 B-clinical_variable
peaks 73 78 2079 2084 I-clinical_variable
) 78 79 2084 2085 O
in 80 82 2086 2088 O
greater 83 90 2089 2096 O
than 91 95 2097 2101 O
or 96 98 2102 2104 O
equal 99 104 2105 2110 O
to 105 107 2111 2113 O
6 108 109 2114 2115 B-lower_bound
of 110 112 2116 2118 O
the 113 116 2119 2122 O
24 117 119 2123 2125 B-upper_bound
V- 120 122 2126 2128 B-clinical_variable
Beta 123 127 2129 2133 I-clinical_variable
T 128 129 2134 2135 I-clinical_variable
- 129 130 2135 2136 I-clinical_variable
cell 130 134 2136 2140 I-clinical_variable
receptor 135 143 2141 2149 I-clinical_variable
families 144 152 2150 2158 O

Mucocutaneous 0 13 2159 2172 B-chronic_disease
candidiasis 14 25 2173 2184 I-chronic_disease
( 26 27 2185 2186 O
chronic 27 34 2186 2193 O
oral 35 39 2194 2198 O
thrush 40 46 2199 2205 B-chronic_disease
or 47 49 2206 2208 O
candida 50 57 2209 2216 B-chronic_disease
esophagitis 58 69 2217 2228 I-chronic_disease
or 70 72 2229 2231 O
candida 73 80 2232 2239 B-chronic_disease
intertriginous 81 95 2240 2254 I-chronic_disease
infection 96 105 2255 2264 I-chronic_disease
or 106 108 2265 2267 O
candida 109 116 2268 2275 B-chronic_disease
nail 117 121 2276 2280 I-chronic_disease
infections 122 132 2281 2291 I-chronic_disease
; 132 133 2291 2292 O
must 134 138 2293 2297 O
be 139 141 2298 2300 O
culture 142 149 2301 2308 O
positive 150 158 2309 2317 O
to 159 161 2318 2320 O
satisfy 162 169 2321 2328 O
this 170 174 2329 2333 O
criterion 175 184 2334 2343 O
) 184 185 2343 2344 O

Must 0 4 2345 2349 O
be 5 7 2350 2352 O
between 8 15 2353 2360 O
2 16 17 2361 2362 B-lower_bound
and 18 21 2363 2366 O
40 22 24 2367 2369 B-upper_bound
years 25 30 2370 2375 I-upper_bound
of 31 33 2376 2378 O
age 34 37 2379 2382 B-age

NK 0 2 2383 2385 B-clinical_variable
cells 3 8 2386 2391 I-clinical_variable
: 8 9 2391 2392 O
absolute 10 18 2393 2401 O
number 19 25 2402 2408 O
less 26 30 2409 2413 O
than 31 35 2414 2418 O
or 36 38 2419 2421 O
equal 39 44 2422 2427 O
to 45 47 2428 2430 O
50 48 50 2431 2433 B-upper_bound
percent 51 58 2434 2441 I-upper_bound
of 59 61 2442 2444 O
LLN 62 65 2445 2448 O

Poor 0 4 2449 2453 O
nutrition 5 14 2454 2463 O
: 14 15 2463 2464 O
Requires 16 24 2465 2473 O
G 25 26 2474 2475 B-treatment
- 26 27 2475 2476 I-treatment
tube 27 31 2476 2480 I-treatment
or 32 34 2481 2483 O
intravenous 35 46 2484 2495 B-treatment
feeding 47 54 2496 2503 I-treatment
supplement 55 65 2504 2514 I-treatment
to 66 68 2515 2517 O
maintain 69 77 2518 2526 O
weight 78 84 2527 2533 O
or 85 87 2534 2536 O
nutrition 88 97 2537 2546 O

Skin 0 4 2547 2551 B-chronic_disease
molluscum 5 14 2552 2561 I-chronic_disease
contagiosum 15 26 2562 2573 I-chronic_disease
OR 27 29 2574 2576 O
warts 30 35 2577 2582 B-chronic_disease
( 36 37 2583 2584 O
this 37 41 2584 2588 O
criterion 42 51 2589 2598 O
is 52 54 2599 2601 O
satisfied 55 64 2602 2611 O
if 65 67 2612 2614 O
molluscum 68 77 2615 2624 O
consists 78 86 2625 2633 O
of 87 89 2634 2636 O
greater 90 97 2637 2644 O
than 98 102 2645 2649 O
or 103 105 2650 2652 O
equal 106 111 2653 2658 O
to 112 114 2659 2661 O
10 115 117 2662 2664 B-lower_bound
lesions 118 125 2665 2672 O
or 126 128 2673 2675 O
there 129 134 2676 2681 O
are 135 138 2682 2685 O
two 139 142 2686 2689 B-lower_bound
or 143 145 2690 2692 O
more 146 150 2693 2697 O
lesions 151 158 2698 2705 O
at 159 161 2706 2708 O
each 162 166 2709 2713 O
of 167 169 2714 2716 O
two 170 173 2717 2720 O
or 174 176 2721 2723 O
more 177 181 2724 2728 O
widely 182 188 2729 2735 O
separated 189 198 2736 2745 O
anatomic 199 207 2746 2754 O
sites 208 213 2755 2760 O
; 213 214 2760 2761 O
or 215 217 2762 2764 O
there 218 223 2765 2770 O
are 224 227 2771 2774 O
greater 228 235 2775 2782 O
than 236 240 2783 2787 O
or 241 243 2788 2790 O
equal 244 249 2791 2796 O
to 250 252 2797 2799 O
3 253 254 2800 2801 B-lower_bound
warts 255 260 2802 2807 O
at 261 263 2808 2810 O
different 264 273 2811 2820 O
anatomic 274 282 2821 2829 O
sites 283 288 2830 2835 O
at 289 291 2836 2838 O
the 292 295 2839 2842 O
same 296 300 2843 2847 O
time 301 305 2848 2852 O
; 305 306 2852 2853 O
or 307 309 2854 2856 O
the 310 313 2857 2860 O
patient 314 321 2861 2868 O
has 322 325 2869 2872 O
both 326 330 2873 2877 O
molluscum 331 340 2878 2887 O
and 341 344 2888 2891 O
warts 345 350 2892 2897 O
) 350 351 2897 2898 O

Treatment 0 9 2899 2908 B-treatment
( 10 11 2909 2910 O
not 11 14 2910 2913 O
prophylaxis 15 26 2914 2925 B-treatment
) 26 27 2925 2926 O
with 28 32 2927 2931 O
systemic 33 41 2932 2940 B-treatment
antibacterial 42 55 2941 2954 I-treatment
, 55 56 2954 2955 I-treatment
antifungal 57 67 2956 2966 I-treatment
or 68 70 2967 2969 I-treatment
antiviral 71 80 2970 2979 I-treatment
antibiotics 81 92 2980 2991 I-treatment
greater 93 100 2992 2999 O
than 101 105 3000 3004 O
or 106 108 3005 3007 O
equal 109 114 3008 3013 O
to 115 117 3014 3016 O
14 118 120 3017 3019 B-lower_bound
days 121 125 3020 3024 I-lower_bound

demonstrated 0 12 3025 3037 O
requirement 13 24 3038 3049 O
for 25 28 3050 3053 O
intravenous 29 40 3054 3065 B-treatment
gamma 41 46 3066 3071 I-treatment
globulin 47 55 3072 3080 I-treatment
( 56 57 3081 3082 I-treatment
IVIG 57 61 3082 3086 I-treatment
) 61 62 3086 3087 I-treatment
( 63 64 3088 3089 O
significant 64 75 3089 3100 O
drop 76 80 3101 3105 O
over 81 85 3106 3110 O
3 86 87 3111 3112 B-lower_bound
to 88 90 3113 3115 O
6 91 92 3116 3117 B-upper_bound
weeks 93 98 3118 3123 I-upper_bound
between 99 106 3124 3131 O
peak 107 111 3132 3136 O
and 112 115 3137 3140 O
trough 116 122 3141 3147 O
IgG 123 126 3148 3151 B-clinical_variable
levels 127 133 3152 3158 I-clinical_variable
) 133 134 3158 3159 O

previously 0 10 3160 3170 O
diagnosed 11 20 3171 3180 O
known 21 26 3181 3186 O
genotype 27 35 3187 3195 O
of 36 38 3196 3198 O
the 39 42 3199 3202 O
subject 43 50 3203 3210 O
conferring 51 61 3211 3221 O
a 62 63 3222 3223 O
predisposition 64 78 3224 3238 O
to 79 81 3239 3241 O
cancer 82 88 3242 3248 B-cancer
( 89 90 3249 3250 O
no 90 92 3250 3252 O
DNA 93 96 3253 3256 O
or 97 99 3257 3259 O
other 100 105 3260 3265 O
testing 106 113 3266 3273 O
for 114 117 3274 3277 O
cancer 118 124 3278 3284 O
predisposition 125 139 3285 3299 O
genes 140 145 3300 3305 O
will 146 150 3306 3310 O
be 151 153 3311 3313 O
performed 154 163 3314 3323 O
as 164 166 3324 3326 O
part 167 171 3327 3331 O
of 172 174 3332 3334 O
the 175 178 3335 3338 O
screen 179 185 3339 3345 O
for 186 189 3346 3349 O
this 190 194 3350 3354 O
protocol 195 203 3355 3363 O
) 203 204 3363 3364 O

weigh 0 5 3365 3370 B-clinical_variable
greater 6 13 3371 3378 O
than 14 18 3379 3383 O
or 19 21 3384 3386 O
equal 22 27 3387 3392 O
to 28 30 3393 3395 O
10 31 33 3396 3398 B-lower_bound
kg 34 36 3399 3401 I-lower_bound

